In Re Schering-Plough Corp. ERISA Litigation

387 F. Supp. 2d 392, 33 Employee Benefits Cas. (BNA) 1023, 2004 U.S. Dist. LEXIS 16265, 2004 WL 1774760
CourtDistrict Court, D. New Jersey
DecidedJune 28, 2004
DocketCiv.A. 03-1204
StatusPublished
Cited by7 cases

This text of 387 F. Supp. 2d 392 (In Re Schering-Plough Corp. ERISA Litigation) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Schering-Plough Corp. ERISA Litigation, 387 F. Supp. 2d 392, 33 Employee Benefits Cas. (BNA) 1023, 2004 U.S. Dist. LEXIS 16265, 2004 WL 1774760 (D.N.J. 2004).

Opinion

OPINION

HAYDEN, District Judge.

Plaintiffs Jingdong Zhu and Adrian Fields (collectively, “plaintiffs”), on behalf of the Schering-Plough Corporation Employee’s Savings Plan (“Savings Plan”) and its participants and beneficiaries (collectively the “Plan Participants”), have filed a five count complaint alleging violations of the Employee Retirement Income Security Act (“ERISA”) against multiple defendants. These defendants are: (1) Scher-ing-Plough Corporation as the employer (“Company”); (2) various members of the board of directors of the Company, all but one of whom were also members of the Company’s Pension Committee (“Directors”); (3) the Schering-Plough Em *394 ployee Benefits Committee and the committee’s individual members (collectively, “Benefits Committee”); (4) the Schering-Plough Employee Benefits Investments Committee and its individual members (collectively, “Investment Committee”); and (5) Vanguard Group, Inc., as the trustee of the Company’s benefits plans (“Trustee”). In lieu of answering, these defendants have joined in a motion to dismiss for failure to state a claim, which was argued to the Court.

DISCUSSION

The Complaint

Plaintiffs’ complaint contains 129 paragraphs of factual allegations. Familiar principles apply: for the purposes of this motion to dismiss, where the complaint presents the only record, plaintiffs’ factual allegations must be accepted as true. Morganroth & Morganroth v. Norris, McLaughlin & Marcus, P.C., 331 F.3d 406, 408 (3d Cir.2003). This Court not need, however, “accept as true ‘unsupported conclusions and unwarranted inferences’ ” set forth in the complaint. Doug Grant, Inc. v. Bonn, 232 F.3d 173, 184-85 (3d Cir.2000) (quotation omitted).

The first of plaintiffs’ allegations describe the various defendants and their respective roles vis-a-vis the Savings Plan that the Company offered to its employees for their retirement savings. Then the complaint describes the Savings Plan itself, which was sponsored by the Company and offered employees an opportunity to invest a percentage of their pre-tax income in their choice among 14 investment vehicles. (Compl.Ex. E.) Although the Savings Plan indicates that the “Company on behalf of Employees may make Salary Deferral Contributions to the Plan,” plaintiffs do not plead that the Company matched employee contributions during the time at issue. All contributions made into the various funds came from the participant employees. (Id.) One of the available fund alternatives was investment in the Scher-ing-Plough Stock Fund (“Stock Fund”), which consisted primarily of shares of the Company’s stock. 1 (Compl.1ffl 32-34.) Plaintiffs challenge the conduct of the defendants relative only to the Stock Fund.

Plaintiffs have alleged that all of the defendants acted as fiduciaries under ERISA with respect to the Stock Fund. (Id. at ¶¶ 33, 58.) Plaintiffs have asserted that the defendants breached their ERISA fiduciaries duties of prudence, care and loyalty by continuing to offer the Stock Fund as a Savings Plan alternative when the defendants knew of the unlawful and artificial inflation of the Company’s stock value. (Id. at ¶ 111.) Additionally, plaintiffs contend that various unidentified defendants, failed to disclose negative material information about the Company, which induced Plan Participants to purchase, hold and maintain investments in Company stock. (Id. at ¶ 117.) Moreover, plaintiffs assert that at least some of the defendants, again not specifically identified, failed to avoid conflicts of interest, to consult with independent fiduciaries, and to monitor appointed fiduciaries, all to the detriment of the Savings Plan and the Plan Participants. (Id. at 116.)

The factual allegations claim that defendants operated the Company in a manner that caused financial harm to the Company, thereby affecting the value of the Stock Fund. (Id. at ¶¶ 69-110.) Specifically, plaintiffs contend that the Company attempted to receive approval from the Food and Drug Administration (“FDA”) of a new allergy drug, Clarinex, to replace the *395 Company’s successful allergy drug, Clari-tin, whose patent was set to expire. The Company’s efforts were significantly hampered because of failures to comply with FDA regulations regarding Good Manufacturing Practices (“GMP’s”). {Id. at ¶¶ 71-73, 77-81, 84-85, 88.) GMP violations led to imposition of a $500 million fine, capital expenditures of $50 million for new equipment and system improvements to remediate violations, and additional hiring of new quality control employees, all to the financial detriment of the Company. {Id. at ¶¶ 91, 95.) Plaintiffs also assert that the defendants touted new potential drugs that never lived up to expectations. {Id. at ¶¶ 98-99, 103-104.) Finally, plaintiffs assert that securities charges brought against the Company, which ultimately resulted in $1 million of civil penalties, also hurt the value of the Stock Fund. {Id. at ¶ 105-107.) Plaintiffs contend that these corporate actions by defendants over a five year period caused the Company’s share price to drop from a value of over $60 per share to a value of below $20 per share, defendants all the while failing to protect the Company’s employees who invested in the Stock Fund from those losses. {Id. at ¶ 109.)

Plaintiffs couch their legal claims in terms of ERISA violations. Count One asserts that defendants breached their fiduciary duties of loyalty, exclusive purpose and prudence as is required under Section 1104(a)(1) of ERISA 2 because they continued to offer the Stock Fund as an investment alternative, thereby permitting Company employees to continue to invest in the Company’s stock, even as its value was dropping. Count Two asserts that certain defendants breached their fiduciary duty to monitor other defendants who were performing ERISA functions. Count Three asserts that because the Stock Fund consisted of Company stock only, the defendants failed to fulfill their fiduciary duty to diversify investment options. Count Four asserts that the defendants breached their fiduciary duty to avoid conflicts of interest by being both corporate officers of the Company and ERISA fiduciaries under the Saving Plan without eliciting the assistance of independent advisors who could make impartial investment recommendations. Count Five asserts that to the extent any of the defendants are not deemed to be ERISA fiduciaries, they are still liable to plaintiffs under a theory of vicarious liability and respondeat superior.

The Savings Plan, the Stock Fund and ERISA

By investing in the Stock Fund, plaintiffs have become shareholders of Company stock and as shareholders of a publicly traded company have certain rights under federal securities law. In fact, a class action lawsuit, invoking these securities laws, has been brought against the Company and is currently pending before this Court (the “Securities Action”). Moreover, this Securities Action is based in large part upon the same factual allegations of wrongdoing as are alleged in this suit.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Harris v. Koenig
602 F. Supp. 2d 39 (District of Columbia, 2009)
In re Polaroid Erisa Litigation
240 F.R.D. 65 (S.D. New York, 2006)
Rogers v. Baxter International Inc.
417 F. Supp. 2d 974 (N.D. Illinois, 2006)
Woods v. Southern Co.
396 F. Supp. 2d 1351 (N.D. Georgia, 2005)
Fisher v. J.P. Morgan Chase & Co.
230 F.R.D. 370 (S.D. New York, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
387 F. Supp. 2d 392, 33 Employee Benefits Cas. (BNA) 1023, 2004 U.S. Dist. LEXIS 16265, 2004 WL 1774760, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-schering-plough-corp-erisa-litigation-njd-2004.